A retrospective analysis of our paclitaxel-eluting stent (Genius TAXCOR I) implantations and follow-up results Paklitaksel salinimli stent (Genius TAXCOR I) uygulamalarimizin izlem sonuçlariyla birlikte geriye dönük deǧerlendirilmesi
Turk Kardiyoloji Dernegi Arsivi, cilt.39, sa.8, ss.675-682, 2011 (Scopus, TRDizin)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 39 Sayı: 8
- Basım Tarihi: 2011
- Doi Numarası: 10.5543/tkda.2011.01318
- Dergi Adı: Turk Kardiyoloji Dernegi Arsivi
- Derginin Tarandığı İndeksler: Scopus, TR DİZİN (ULAKBİM)
- Sayfa Sayıları: ss.675-682
- Anahtar Kelimeler: Coronary angiography, coronary artery disease, coronary restenosis, paclitaxel, stents
- Sağlık Bilimleri Üniversitesi Adresli: Hayır
Özet
Objectives: We evaluated our paclitaxel-eluting stent (Genius TAXCOR I) implantations and follow-up results in patients with coronary artery disease. Study design: The study included 101 patients (75 men, 26 women; mean age 60±10 years) who underwent elective paclitaxel-eluting stent deployment for de novo native coronary artery lesions. Sixteen patients received two stents. Lesion types were as follows: type A (23.9%), type B1 (29.1%), type B2 (32.5%), and type C (14.5%). Twelve lesions (10.3%) exhibited mild tortuosity, 32 (27.4%) had mild calcification, 12 had (10.3%) an angulation of more than 45 degrees, while eight (7.7%) had thrombus. Following stent implantation, the patients were examined at 1, 6, and 12 months, and annually thereafter. The mean followup period was 48.9±5.7 months (range 35 to 60 months). Results: Stent implantation was successful in all the patients. The mean diameter stenosis was 82.8±9.9%, the mean stent diameter was 3.1±0.6 mm, and the mean stent length was 16.0±5.2 mm. During the follow-up period, 46 patients (45.5%) required coronary angiography, of which eight (17.4%) received target vessel revascularization, and four (8.7%) received target lesion revascularization. One patient (1.0%) died from sudden cardiac death. Conclusion: The clinical and angiographic follow-up results of this study involving relatively low- and intermediate-risk patients indicate that the use of the Genius TAXCOR I stents is effective and beneficial for the prevention of stent thrombosis and restenosis. © 2011 Türk Kardiyoloji Derneǧi.